Novartis, Others Win $400M In HHS Vaccine Center Contracts

Law360, New York (June 18, 2012, 6:39 PM EDT) -- Federal health officials on Monday awarded $400 million in contracts to Novartis AG, Emergent BioSolutions Inc. and Texas A&M University to lead centers that will develop and manufacture vaccines, medicines and other remedies for national medical emergencies such as bioterrorism and flu pandemics.

The U.S. Department of Health and Human Services announced the establishment of the three centers, dubbed the Centers for Innovation in Advanced Development and Manufacturing, which it claims will help bring medical countermeasures to the market faster and help train future biopharmaceutical workers....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.